Breaking News Instant updates and real-time market news.

RIG

Transocean

$5.43

-0.25 (-4.40%)

, COMM

CommScope

$15.85

-0.55 (-3.35%)

10:17
06/14/19
06/14
10:17
06/14/19
10:17

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Transocean (RIG) downgraded to Neutral from Buy at Citi with analyst Scott Gruber saying his organic cash burn analysis implies the drillers will burn cash until "at least" 2021. 2. CommScope (COMM) downgraded to Outperform from Strong Buy at Raymond James with analyst Simon Leopold saying he is concerned that performance of the acquired ARRIS business will be worse than expected. 3. Spirit AeroSystems (SPR), Astronics (ATRO), and Barnes Group (B) were downgraded to Sell from Hold at SunTrust while Woodward (WWD) and Ducommun (DCO) were downgraded to Hold from Buy. 4. Melinta Therapeutics (MLNT) downgraded to Underweight from Neutral at JPMorgan with analyst Eric Joseph saying while a market cap valuation of $20M-25M "begs the questions of whether shares have yet reached bottom," he believes the answer is "no." 5. Ashland (ASH) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RIG

Transocean

$5.43

-0.25 (-4.40%)

COMM

CommScope

$15.85

-0.55 (-3.35%)

WWD

Woodward

$112.58

-2.79 (-2.42%)

SPR

Spirit AeroSystems

$80.45

-3.12 (-3.73%)

ATRO

Astronics

$40.91

-3.26 (-7.38%)

DCO

Ducommun

$44.65

-2.28 (-4.86%)

B

Barnes Group

$54.03

-2.3 (-4.08%)

MLNT

Melinta Therapeutics

$1.69

-0.17 (-9.14%)

ASH

Ashland

$79.46

-0.64 (-0.80%)

  • 21

    Jun

  • 27

    Jun

  • 28

    Jun

RIG Transocean
$5.43

-0.25 (-4.40%)

06/14/19
SBSH
06/14/19
DOWNGRADE
Target $6.7
SBSH
Neutral
Transocean downgraded to Neutral from Buy at Citi
Citi analyst Scott Gruber downgraded Transocean to Neutral from Buy and cut his price target for the shares to $6.70 from $11. The analyst says his organic cash burn analysis implies the drillers will burn cash until "at least" 2021. His base case has floater utilization remaining below 70% by 2022, "well below the level needed to see significant pricing power."
05/01/19
RBCM
05/01/19
NO CHANGE
Target $30
RBCM
Outperform
Transocean added to 'Global Energy Best Ideas List' at RBC Capital
RBC Capital analyst Kurt Hallead kept his Outperform rating and $30 price target on Transocean but added the stock to his RBC Global Energy Best Ideas List after its 10% price decline yesterday. The analyst contends that the offshore drilling cycle is gaining momentum as seen in the "increased utilization and pricing for a variety of assets" across several regions. Hallead is also positive on Transocean's inventory of deepwater rigs as well as its "ample liquidity" to pay off the debt maturing in the next few years.
06/14/19
SBSH
06/14/19
DOWNGRADE
SBSH
Neutral
Transocean downgraded to Neutral from Buy at Citi
06/10/19
BOFA
06/10/19
INITIATION
Target $6.5
BOFA
Neutral
Transocean reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Chase Mulvehill reinstated coverage of Transocean with a Neutral rating and $6.50 price target. While Transocean is the largest offshore driller globally, Mulvehill tells investors in a research note that he thinks its backlog's cash flow benefit is offset by its high leverage and near term capital requirements, restricting its ability to generate free cash flow until 2022. Notwithstanding the estimated ~$1B cash burn through year-end 2021, the analyst contends that Transocean looks the best on valuation, balance sheet and contract coverage in his oil space coverage.
COMM CommScope
$15.85

-0.55 (-3.35%)

06/14/19
RAJA
06/14/19
DOWNGRADE
Target $21
RAJA
Outperform
CommScope downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Simon Leopold downgraded CommScope Holding to Outperform from Strong Buy and lowered his price target for the shares to $21 from $25.
06/14/19
RAJA
06/14/19
DOWNGRADE
Target $21
RAJA
Outperform
Raymond James downgrades CommScope to Outperform on ARRIS concerns
As previously reported, Raymond James analyst Simon Leopold downgraded CommScope Holding to Outperform from Strong Buy, stating that he is concerned that performance of the acquired ARRIS business will be worse than expected. Operators' transitions to virtualized architectures have decreased the prospects for recovery from the CCAP portion of ARRIS, said Leopold, who lowered his price target for CommScope shares to $21 from $25. However, he notes that he still expects favorable trends in other segments along with strong cash generation from CommScope.
06/12/19
06/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. NXP Semiconductors (NXPI) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Craig Hettenbach saying he sees relative value in the stock after the shares have underperformed peers by 73% during the last three years. 2. AllianceBernstein (AB) upgraded to Buy from Neutral at Goldman Sachs with analyst Alexander Blostein saying the company's "leading" organic fee growth is not priced into the shares at current levels. 3. Brinker (EAT) upgraded to Outperform from Market Perform at Telsey Advisory. 4. CymaBay (CBAY) upgraded to Strong Buy from Outperform at Raymond James with analyst Steven Seedhouse citing the upside potential he sees following the pullback in the stock. 5. CommScope (COMM) upgraded to Buy from Neutral at Rosenblatt with analyst Ryan Koontz saying "surging" fiber spending ahead of 5G buildouts, led by Verizon (VZ), improves the outlook of select companies in the communications equipment sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/12/19
RSBL
06/12/19
UPGRADE
Target $22
RSBL
Buy
CommScope upgraded to Buy from Neutral at Rosenblatt
Rosenblatt analyst Ryan Koontz upgraded CommScope to Buy from Neutral while lowering his price target for the shares to $22 from $24. "Surging" fiber spending ahead of 5G buildouts, led by Verizon (VZ), improves the outlook of select companies in the communications equipment sector, Koontz tells investors in a research note. Further, he expects CommScope to see improved cable sales in the second half of 2019 ahead of a border 5G deployment in 2020.
WWD Woodward
$112.58

-2.79 (-2.42%)

04/30/19
RHCO
04/30/19
NO CHANGE
Target $118
RHCO
Buy
Woodward price target raised to $118 from $110 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on Woodward (WWD) to $118 and kept his Buy rating after its Q2 earnings beat and raised outlook for FY19. The analyst says the company's Aerospace segment is benefiting from strength across its markets and does not expect it to be affected by Boeing's (BA) 737 MAX grounding. Ciarmoli also points to the 16% organic growth of Woodward's Industrial segment and outperformance in its recent L'Orange acquisition.
06/14/19
RHCO
06/14/19
DOWNGRADE
RHCO
Hold
Woodward downgraded to Hold from Buy at SunTrust
SunTrust analyst Michael Ciarmoli downgraded Woodward Hold from Buy.
04/18/19
WBLR
04/18/19
INITIATION
WBLR
Outperform
Woodward initiated with an Outperform at William Blair
William Blair analyst Nicholas Heymann started Woodward (WWD) with an Outperform rating saying the stock offers 15%-20% upside over the next 6-12 months. After six years of "robust" investment for new capacity and products, Woodward is entering a period of accelerating profitable organic growth. He believes the company is "exceptionally well positioned" to generate "sustainable" double-digit earnings growth despite the current Boeing (BA) 737 Max grounding.
SPR Spirit AeroSystems
$80.45

-3.12 (-3.73%)

06/14/19
RHCO
06/14/19
DOWNGRADE
Target $75
RHCO
Sell
Spirit AeroSystems downgraded to Sell from Hold at SunTrust
SunTrust analyst Michael Ciarmoli downgraded Spirit AeroSystems to Sell from Hold and lowered his price target for the shares to $75 from $93.
04/08/19
ADAM
04/08/19
DOWNGRADE
ADAM
Hold
Spirit AeroSystems downgraded to Hold from Buy at Canaccord
04/08/19
ADAM
04/08/19
DOWNGRADE
Target $92
ADAM
Hold
Spirit AeroSystems downgraded to Hold from Buy at Canaccord
Canaccord analyst Ken Herbert downgraded Spirit AeroSystems (SPR) to Hold from Buy and lowered his price target to $92 from $100 after Boeing (BA) announced that it is lowering 737 production levels to 42 per month starting in mid-April. In a research note to investors, Herbert says that while Spirit has said it will continue to produce at a rate of 52 per month, he feels the slight adjustment adds incremental margin and free cash flow pressure in 2019, and believes the 737 MAX grounding will contribute to near-term headline risk.
ATRO Astronics
$40.91

-3.26 (-7.38%)

06/14/19
RHCO
06/14/19
DOWNGRADE
Target $36
RHCO
Sell
Astronics downgraded to Sell from Hold at SunTrust
SunTrust analyst Michael Ciarmoli downgraded Astronics to Sell from Hold and lowered his price target for the shares to $36 from $41.
05/01/19
GHSC
05/01/19
INITIATION
Target $42
GHSC
Buy
Astronics initiated with a Buy at Seaport Global
Seaport Global analyst Josh Sullivan initiated Astronics with a Buy and $42 price target saying it is exiting an "significant" investment cycle and its Armstrong, AeroSat and CCC businesses are now nearing an inflection point. Also, Astronics' Ku-band antenna will be used for Satcom Direct's Xperience, taking business jets from dial-up to modern internet speeds. Sullivan notes Astronics strong positioning on high-speed connectivity and narrow-body power supply, as well as an improving balance sheet
DCO Ducommun
$44.65

-2.28 (-4.86%)

06/14/19
RHCO
06/14/19
DOWNGRADE
Target $45
RHCO
Hold
Ducommun downgraded to Hold from Buy at SunTrust
SunTrust analyst Michael Ciarmoli downgraded Ducommun to Hold from Buy and lowered his price target for the shares to $45 from $54.
05/22/19
SIDC
05/22/19
DOWNGRADE
SIDC
Neutral
Ducommun downgraded to Neutral from Buy at Sidoti
Sidoti analyst Edward Marshall downgraded Ducommun to Neutral from Buy, stating that though he thinks margin improvement will continue, he also thinks the Q1 report raised investor expectations and he sees limited upside to his $53 price target on the stock following the recent 20% run-up following earnings.
05/13/19
NBLE
05/13/19
DOWNGRADE
NBLE
Market Perform
Ducommun downgraded to Market Perform from Outperform at Noble Capital
B Barnes Group
$54.03

-2.3 (-4.08%)

06/14/19
06/14/19
DOWNGRADE

Hold
Astronics, Barnes Group, Ducommun, Woodward, Spirit Aero downgraded at SunTrust
As previously reported, SunTrust analyst Michael Ciarmoli downgraded Astronics (ATRO) to Sell, Barnes Group (B) to Sell, Ducommun (DCO) to Hold, Woodward (WWD) to Hold, and Spirit Aerosystems to Sell as part of his broader Aerospace research note highlighting the "ongoing" Boeing (BA) 737 Max uncertainty. The analyst says the risks related to the aircraft production will "ripple across the sector" over the next 12-24 months and spark outlook revisions for the supply chain in 2019-2020. Ciarmoli believes however that the downgrade will be "short term" in nature until there is better clarity around the timing of 737 Max certification, resumption of flight, and future production rates. The analyst's price target reductions on the supplier are as follows: Astronics down to $36 from $41, Barnes Group to $48 from $53, Ducommun to $48 from $54, Spirit Aerosystems to $75 from $93, and Woodward to $110 from $118.
04/11/19
DADA
04/11/19
NO CHANGE
Target $56
DADA
Neutral
Barnes Group price target lowered to $56 from $58 at DA Davidson
DA Davidson analyst Matt Summerville lowered his price target on Barnes Group to $56 and kept his Neutral rating. The analyst believes that a challenging organic environment in the company's Industrial segment is likely to persist into the second half of the year given the "sluggish global auto environment, incremental general slowing in Europe and China, and the unresolved tariff situation." Summerville also lowers his FY19 and FY20 EPS view by 5c and 8c to $3.20 and $3.50 respectively to reflect his reduced expectations for Barnes Group's Industrial business.
05/16/19
ALMG
05/16/19
INITIATION
Target $67
ALMG
Overweight
Barnes Group initiated with an Overweight at Alembic Global
Alembic Global started Barnes Group with an Overweight rating and $67 price target.
06/14/19
RHCO
06/14/19
DOWNGRADE
Target $48
RHCO
Sell
Barnes Group downgraded to Sell from Hold at SunTrust
SunTrust analyst Michael Ciarmoli downgraded Barnes Group to Sell from Hold and lowered his price target for the shares to $48 from $53.
MLNT Melinta Therapeutics
$1.69

-0.17 (-9.14%)

06/14/19
JPMS
06/14/19
DOWNGRADE
JPMS
Underweight
JPMorgan downgrades Melinta to Underweight, says shares have not bottomed
JPMorgan analyst Eric Joseph downgraded Melinta Therapeutics to Underweight from Neutral without a price target. The analyst says that while a market cap valuation of $20M-25M "begs the questions of whether shares have yet reached bottom," he believes the answer is "no." Melinta fundamentally remains a launch turnaround story, with market access being the chief priority over the next 6-12 months, Joseph tells investors in a research note. The analyst believes payer coverage and prescription trends reflect "minimal traction and lost ground to generics." As such, he sees Melinta shares continuing to be under pressure for the "foreseeable horizon."
05/10/19
GABE
05/10/19
DOWNGRADE
GABE
Sell
Melinta Therapeutics downgraded to Sell from Hold at Gabelli
Gabelli analyst Kevin Kedra downgraded Melinta Therapeutics to Sell from Hold citing concerns about its loan covenants following the company's Q1 report.
05/10/19
JEFF
05/10/19
DOWNGRADE
Target $5
JEFF
Hold
Jefferies downgrades Melinta to Hold on 'deteriorating' fundamentals
Jefferies analyst David Hoang downgraded Melinta Therapeutics to Hold from Buy and cut his price target for the shares to $5 from $14. The analyst sees "deteriorating" fundamentals with the company's antibiotics sales ramping "too slowly." The analyst does not see meaningful way for Melinta to drive an inflection in antibiotics sales absent macro changes.
06/14/19
JPMS
06/14/19
DOWNGRADE
JPMS
Underweight
Melinta Therapeutics downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Eric Joseph downgraded Melinta Therapeutics to Underweight from Neutral.
ASH Ashland
$79.46

-0.64 (-0.80%)

05/24/19
JEFF
05/24/19
NO CHANGE
Target $93
JEFF
Buy
Ashland shares have 30% upside potential in next year, says Jefferies
Jefferies analyst Laurence Alexander sees around 30% upside potential in shares of Ashland over the next year, "even in a choppy environment." A combination of "fairly resilient" end-markets, a favorable mix shift opportunity, and a multi-year tailwind from cost-cutting makes an 11 times EBITDA multiple achievable, Alexander tells investors in a research note. He raised his price target for Ashland to $93 from $90 and keeps a Buy rating on the shares.
04/09/19
JPMS
04/09/19
DOWNGRADE
Target $51
JPMS
Neutral
JPMorgan downgrades H.B. Fuller to Neutral on fair valuation
JPMorgan analyst Jeffrey Zekauskas downgraded H.B. Fuller (FUL) to Neutral from Overweight with an unchanged price target of $51. The analyst views the shares as valued fairly at current levels and sees better opportunity in semi-commodity peers such as Eastman Chemical (EMN), Cabot (CBT) or Ashland (ASH). He says the other names offer a higher free cash flow yield, lower leverage or lower enterprise value to EBITDA multiples. Volume growth at H.B. Fuller has slowed with the global economy, particularly in China, Europe and the United States, Zekauskas tells investors in a research note.
06/14/19
JPMS
06/14/19
DOWNGRADE
Target $82
JPMS
Neutral
Ashland downgraded to Neutral on valuation at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Ashland Global Holdings to Neutral from Overweight with an unchanged price target of $82. The analyst cites valuation for the downgrade the stock trading just below his December 2019 price target. He estimates Ashland's free cash flow yield at about 3.4% for fiscal 2019 and between 5.5% and 6.0% for fiscal 2020.
06/14/19
JPMS
06/14/19
DOWNGRADE
Target $82
JPMS
Neutral
Ashland downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Ashland Global Holdings to Neutral from Overweight with an unchanged price target of $82.

TODAY'S FREE FLY STORIES

VZ

Verizon

$57.00

-1.01 (-1.74%)

08:26
06/27/19
06/27
08:26
06/27/19
08:26
Periodicals
Huawei in talks with Verizon over royalty payments for patents, CNBC reports »

Huawei is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Hot Stocks
Dova Pharmaceuticals announces FDA approval of sNDA for DOPTELET »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 30

    Jun

WBC

Wabco

$131.95

-0.23 (-0.17%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Conference/Events
Wabco to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:24
06/27/19
06/27
08:24
06/27/19
08:24
Initiation
Tesla initiated  »

Tesla initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:23
06/27/19
06/27
08:23
06/27/19
08:23
Hot Stocks
Ovid Therapeutics initiates Phase 3 trial of OV101 »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$183.53

1.54 (0.85%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$77.84

0.82 (1.06%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.46

0.99 (1.58%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$41.55

0.05 (0.12%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Initiation
BorgWarner initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

XLY

Consumer Discretionary Sector SPDR

$118.12

0.35 (0.30%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.80

-0.12 (-0.21%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADAP

Adaptimmune

$4.07

0.07 (1.75%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Hot Stocks
Adaptimmune CFO Adrian Rawcliffe to succeed James Noble as CEO »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BC

Brunswick

$45.29

0.2 (0.44%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$59.33

-1.3 (-2.14%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Conference/Events
Dova Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

XLP

Consumer Staples Sector SPDR

$57.99

-0.82 (-1.39%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$91.62

-1.23 (-1.32%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$150.83

-0.31 (-0.21%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.